Aug 2 |
Alnylam (ALNY) Up as Q2 Earnings Beat on Collaboration Revenues
|
Aug 2 |
Regeneron's Robust Pipeline And Financial Health Signal Continued Growth
|
Aug 2 |
Q2 2024 Regeneron Pharmaceuticals Inc Earnings Call
|
Aug 1 |
Regeneron Pharmaceuticals' Q2 Earnings Exceed Estimates, Driven By Its Top-Selling Eczema And Eye Drugs
|
Aug 1 |
Defensive Sectors Breakout: 3 Stocks to Buy Now for Protection
|
Aug 1 |
Regeneron Pharmaceuticals, Inc. (REGN) Q2 2024 Earnings Call Transcript
|
Aug 1 |
Compared to Estimates, Regeneron (REGN) Q2 Earnings: A Look at Key Metrics
|
Aug 1 |
Regeneron (REGN) Tops on Q2 Earnings, Eylea HD, Dupixent Fuel Sales
|
Aug 1 |
Regeneron beats quarterly results on strong demand for eczema, eye treatments
|
Aug 1 |
Regeneron beats in Q2 as Eylea tops expectations
|